[PAX gene function during kidney tumorigenesis: a comparative approach].

Abstract:

:The rising incidence of cancers affecting the kidney emphasizes the need to identify the molecular pathways involved in the initiation and progression of kidney tumors in order to counter this phenomenon. For many years, genes belonging to the PAX family have been the focus of intensive studies in the fields of organogenesis and tumorigenesis. PAX2 and PAX8 encode transcription factors essential for embryonic kidney development. Transcriptionnal repression of these factors is, however, required to allow terminal differentiation of renal epithelia. In human, maintenance and reactivation of PAX2/8 expression are frequently observed in cases of Wilm's tumor and renal cell carcinoma. The precise role of PAX2/8 in kidney cancer is still elusive but results from several studies suggest the exertion of common functions during organogenesis and tumorigenesis of the kidney. Moreover, many members of the PAX family are involved in similar cellular processes such as differentiation/proliferation, motility and apoptosis. Thus, by comparing the functions exerted by PAX factors in several types of cancers should be useful to better define the specific contribution of PAX2/8 to kidney tumorigenesis.

journal_name

Bull Cancer

journal_title

Bulletin du cancer

authors

Béland M,Bouchard M

subject

Has Abstract

pub_date

2006-09-01 00:00:00

pages

875-82

issue

9

eissn

0007-4551

issn

1769-6917

journal_volume

93

pub_type

杂志文章,评审
  • [Cognitive impairments and breast cancer: a critical review of the literature].

    abstract::Since the 1980's, women treated for breast cancer are reporting moderate cognitive impairments during and after chemotherapy. These cognitive impairments may be related to chemotherapy but also to hormone therapy, psychological distress, fatigue... This work is a critical review of the literature, which reports types ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2008.0818

    authors: Vandenbossche S,Fery P,Razavi D

    更新日期:2009-02-01 00:00:00

  • [Understanding positon emission tomography (PET) with [18F]-FDG in clinical oncology. Informations dedicated to patients and relatives].

    abstract::In response to the evolution of the information-seeking behaviour of patients and concerns from health professionals regarding cancer patient information, the French National Federation of Comprehensive Cancer Centres (FNCLCC) introduced, in 1998, an information and education program dedicated to patients and relative...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,病人教育讲义

    doi:

    authors: Bourguet P,Brusco S,Corone C,Devillers A,Foehrenbach H,Lumbroso JD,Maszelin P,Montravers F,Moretti JL,Rain JD,Talbot JN,Carretier J,Leichtnam-Dugarin L,Delavigne V,Philip T,Fervers B,Fédération nationale des centres de lu

    更新日期:2005-07-01 00:00:00

  • [Improving doctor's communication skills in oncology: review and future perspectives].

    abstract::The aim of this review is to discuss the different communication skills training designed to physician interactions with cancer patients. The development of medicine and chronic cancer treatments indicates the need to improve communication skills that combine appropriate assessment, information and support. Literature...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Libert Y,Conradt S,Reynaert C,Janne P,Tordeurs D,Delvaux N,Fontaine O,Razavi D

    更新日期:2001-12-01 00:00:00

  • Expression of class III beta tubulin in non-small cell lung cancer is correlated with resistance to taxane chemotherapy.

    abstract::This study determined the prevalence and the prognostic value of the expression of microtubule components in tumors of 19 patients with non small cell lung cancer receiving taxane-based regimens. Patient samples were stained with antibodies directed against total beta tubulin, classes I, II and III beta tubulin isotyp...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Dumontet C,Isaac S,Souquet PJ,Bejui-Thivolet F,Pacheco Y,Peloux N,Frankfurter A,Luduena R,Perol M

    更新日期:2005-02-01 00:00:00

  • [Breast cancer's impact on work life. Survey among women of the ELIPPSE cohort].

    abstract::Working people who are diagnosed with cancer must generally stop working, and returning to work after treatment is a very important issue for them. This article investigates the impact of cancer on professional trajectory among working women after a breast cancer diagnosis. We conducted in-depth interviews with 21 wom...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1684/bdc.2012.1611

    authors: Gallardo L,Rey D,Peretti-Watel P

    更新日期:2012-07-01 00:00:00

  • [Hepatic transport of mitoxantrone in relation to multiple resistance].

    abstract::We have examined the effect of cyclosporin A on transport processes (uptake, efflux, binding) of mitoxantrone in isolated rat liver cells. Accumulation and binding of mitoxantrone was rapid with or without cyclosporin A. The initial uptake was linear over a wide concentration range (1 to 1000 microM). For the first 10...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Coloma F,Lacarelle B,Poitou P,Filleul A,Covo J,Catalin J

    更新日期:1994-05-01 00:00:00

  • [WHO classification of head and neck tumours 2017: Main novelties and update of diagnostic methods].

    abstract::The publication of the new WHO classification of head and neck tumours in 2017 brought major modifications. Especially, a new chapter is dedicated to the oropharynx, focusing on the description of squamous cell carcinoma induced by the virus Human Papilloma Virus (HPV), and new entities of tumors are described in nasa...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1016/j.bulcan.2018.04.004

    authors: Sarradin V,Siegfried A,Uro-Coste E,Delord JP

    更新日期:2018-06-01 00:00:00

  • [Frequency of cancer at older ages].

    abstract::The dependency between the risk of death and age is analysed, and the contribution of cancer to the overall risk of death is evaluated as a function of age. The frequency of the different cancer sites is described in different age groups. Lastly cancer mortality trends are presented by age. The risk of death from canc...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1684/bdc.2007.0531

    authors: Hill C,Doyon F

    更新日期:2008-05-28 00:00:00

  • [Response in patients with melanoma to immunization using melanoma oncolysates of vaccine virus].

    abstract::Thirty-two patients with high risk melanoma (either primary melanoma of the limbs or trunk, or recurrent melanoma) and clinically disease-free following appropriate surgical treatment were immunized with a vaccinia virus oncolysate made from a pool of 4 human melanoma cell lines. Injections were given id weekly for 3 ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Doré JF,Portoukalian J,Berthier-Vergnes O,Jacubovich R,Genève J,Bailly M,Lefthériotis E,Weissbrod A,Mayer M

    更新日期:1990-01-01 00:00:00

  • [Prerequisite for hematopoietic cellular therapy programs to set up chimeric antigen receptor T-cell therapy (CAR T-cells): Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].

    abstract::CAR T-cells are autologous or allogeneic human lymphocytes that are genetically engineered to express a chimeric antigen receptor targeting an antigen expressed on tumor cells such as CD19. CAR T-cells represent a new class of medicinal products, and belong to the broad category of Advanced Therapy Medicinal Products ...

    journal_title:Bulletin du cancer

    pub_type: 共识发展会议,杂志文章,实务指引

    doi:10.1016/j.bulcan.2017.10.017

    authors: Yakoub-Agha I,Ferrand C,Chalandon Y,Ballot C,Castilla Llorente C,Deschamps M,Gauthier J,Labalette M,Larghero J,Maheux C,Moreau AS,Varlet P,Pétillon MO,Pinturaud M,Rubio MT,Chabannon C

    更新日期:2017-12-01 00:00:00

  • [The management of the metastatic disease by the surgeons].

    abstract::The high rate of recurrence after apparently complete surgery and/or complete clinical response to chemotherapy implies that most patients have undetected minimal residual disease. Novel techniques such as laparoscopic or laparotomic fluorescence may prove to be crucial in reassessing the definition of primary outcome...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1684/bdc.2013.1730

    authors: Mery E,Golzio M,Thibault B,Ferron G,Querleu D,Delord JP,Couderc B

    更新日期:2013-04-01 00:00:00

  • [Portal vein embolization: Present and future].

    abstract::Portal vein embolization consists of occluding a part of the portal venous system in order to achieve the hypertrophy of the non-embolized liver segments. This technique is used during the preoperative period of major liver resection when the future remnant liver (FRL) volume is insufficient, exposing to postoperative...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1016/j.bulcan.2017.03.009

    authors: Piron L,Deshayes E,Escal L,Souche R,Herrero A,Pierredon-Foulongne MA,Assenat E,le Lam N,Quenet F,Guiu B

    更新日期:2017-05-01 00:00:00

  • [Medicinal plants in cancer patients: current practices and evaluation data].

    abstract::Many complementary and alternatives medicines are offered to patients with cancer. Among them, herbal medicines have a substantial place. These plants are mainly used to reduce adverse effects of anticancer treatments and for specific anticancer properties. Our review shows that only few clinical data support medicina...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2013.1741

    authors: Huet M

    更新日期:2013-05-01 00:00:00

  • [Evaluation of professional practices: improving cancer related-pain management in radiation oncology].

    abstract::Radiation oncologist often faced cancer pain, regardless the stage of cancer. Given the high prevalence of cancer pain, and its potential for profound adverse consequences, all patients with active malignancy should be routinely screened and treated for pain. Using a questionnaire developed by the pain center of the I...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1684/bdc.2012.1630

    authors: Auberdiac P,Levy A,Guy JB,Malkoun N,Moncharmont C,Chargari C,Michaud P,De Laroche G,Magné N

    更新日期:2012-09-01 00:00:00

  • [Esophageal cancer in Western France. Retrospective analysis of 1400 cases].

    abstract::A retrospective review was made of 1 400 cases of cancer of the esophagus treated at the Centre "Francois Baclesse" between 1964 and 1975. The disease appeared at an earlier age and more frequently in men (95%) than in women. The lesions were located predominantly in the middle third of the esophagus. There was a high...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Roussel A,Gignoux M,Verwaerde JC,Segol P,Abbatucci JS,Valla A

    更新日期:1977-01-01 00:00:00

  • [Morphine therapy: evaluation of patient information].

    abstract::Pain is frequent in the course of cancer and can have negative consequences on patients quality of life. The great majority of patients can be helped by simple treatments. The prescription of morphine (M) must be preceded by some explanations. In order to verify the reality of these explanations, a study was done in a...

    journal_title:Bulletin du cancer

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:

    authors: Ranchere JY,Delfosse MH,Saltel P,Latour JF

    更新日期:1998-04-01 00:00:00

  • [Announcing cancer diagnosis: which communication difficulties from professional and from patient's side? Which possible improvements?].

    abstract::Announcing a cancer diagnosis, but also a relapse, a progression of the disease, or transition towards palliative care constitute particularly difficult communication issues for the patient as well as for the clinician, during the trajectory of care. The objectives of this article is to present the clinical stakes of ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1684/bdc.2010.1197

    authors: Dolbeault S,Brédart A

    更新日期:2010-10-01 00:00:00

  • [Acute cerebellar syndrome after treatment with 5-fluorouracil].

    abstract::We report on a case of 5-fluorouracil induced neurotoxicity during 5-fluorouracil cisplatin combination chemotherapy for advanced head and neck squamous cell carcinoma. The initial manifestations included an acute cerebellar syndrome and peripheral neuropathy. Computed tomography of the brain was normal. The results o...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Barbieux C,Patri B,Cerf I,de Parades V

    更新日期:1996-01-01 00:00:00

  • [Treatment of mucositis pain: News and prospects].

    abstract::Mucositis, an acute inflammation of the digestive mucosa, is one of the main toxicities secondary to oncological treatments. Among its consequences, mucositis-related pain is an important complication due to its intensity and repercussion, especially on quality of life. Treatment of pain plays a central role in manage...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1016/j.bulcan.2019.03.022

    authors: Guerrini-Rousseau L,Marec-Berard P,Bolle S,Laurent S

    更新日期:2019-09-01 00:00:00

  • Factors controlling immunoglobulin production and B cell proliferation.

    abstract::The proliferation and the differentiation of B lymphocytes is under the control of T cell and macrophage produced cytokines which drive resting B cells to the state of antibody-producing plasma cells. Antibodies exert a feedback control of their own production via their interaction with Fc receptor (FcR) bearing cells...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Fridman WH

    更新日期:1991-01-01 00:00:00

  • [Proton therapy in soft tissue and bone sarcomas].

    abstract::Sarcomas are a common type of tumor within the pediatric population. The utilization of proton therapy as a primary attribute the ability to spare adjacent healthy tissue, therefore, proton therapy has become a preferential indication in pediatrics compared to other photon irradiation modalities. Proton therapy is als...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1016/j.bulcan.2018.05.008

    authors: Thariat J,Tessonnier T,Bonvalot S,Lerouge D,Mammar H,Bolle S,Claren A,Duffaud F,Alapetite C,Vogin G

    更新日期:2018-09-01 00:00:00

  • [Stakes, aims and specificities of the physician-patient communication in cancer care: state of the art and perspectives].

    abstract::The physician-patient relationship has three main stakes : creating a high-quality inter-personal relationship, exchanging information and decision-making. The achievement of these stakes implies that the physician and the patient are able to reach specific communicational objectives. The aim of this paper is to revie...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Libert Y,Merckaert I,Reynaert C,Razavi D

    更新日期:2006-04-01 00:00:00

  • [Metastatic breast cancer: controlled trial of chemotherapy with and without hormones].

    abstract::Two hundred and twenty-three patients with disseminated breast cancer entered in a randomized trial: Group I: 130 patients were given a monthly 5 day- course of a cytotoxic chemotherapy protocol including Adriamycine, Vincristine, Cyclophosphamide, 5 Fluoro-uracile (A.V.L.F.); Group II: 93 patients were given alternat...

    journal_title:Bulletin du cancer

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:

    authors: Jouve M,Palangie T,Garcia-Giralt E,Bretaudeau B,Magdelenat H,Asselain B,Pouillart P

    更新日期:1984-01-01 00:00:00

  • [Recent therapeutic trends in triple-negative metastatic breast cancers: PARP inhibitors, immunotherapies and antibody-drug conjugates].

    abstract::Compared with other breast cancer subtypes, patients with metastatic triple-negative breast cancer (TNBC) are younger and have a worst overall survival with a median of 15 to 18 months. These tumors have long suffered from a purely negative definition, but the last few years have witnessed many breakthrough genomic an...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1016/j.bulcan.2020.11.007

    authors: Dalenc F,Sarradin V,Nicolaï V,Franchet C,Ung M

    更新日期:2021-01-01 00:00:00

  • [Gliomas and BRCA genes mutations: fortuitous association or imputability?].

    abstract::BRCA is a tumor suppressor gene implicated in the major mechanisms of cellular stability in every type of cell. Its mutations are described in numerous cancers, mainly breast and ovarian in women. It was also found an increase of lifetime risk of pancreas, colon, prostate cancer or lymphoma in men carriers. We report ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1684/bdc.2014.1952

    authors: Girardstein-Boccara L,Mari V,Met-Domestici M,Burel-Vandenbos F,Berthet P,Paquis P,Frenay MP,Lebrun-Frenay C

    更新日期:2014-09-01 00:00:00

  • [Multidisciplinary treatment of soft tissue sarcomas: an improvement in prognosis (author's transl)].

    abstract::The results obtained in the treatment of 45 cases of soft tissue sarcomas are presented. All cases were reviewed and classified according to the modern criteria of malignancy. The treatment schedule comprised: (1) preoperative irradiation: 2 sessions of 6.50 Gy in 48 hours, target volume: whole limb segment; (2) surgi...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Abbatucci JS,Boulier N,Mandard AM,de Ranieri J,Tanguy A,Chasle J

    更新日期:1981-01-01 00:00:00

  • [Immunotherapy of metastatic non-small cell lung cancer from first line to resistance and its management].

    abstract::Immunotherapy alone or in combination with chemotherapy is now an integral part of the treatment of metastatic NSCLC. This treatment is transforming the management of these cancers, with 20-30% of patients achieving long survival. However, disease progression under treatment is still the rule for the majority of patie...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1016/j.bulcan.2020.04.018

    authors: Basse C,Swalduz A,Levra MG,Girard N,Remon J,Moro-Sibilot D

    更新日期:2020-01-01 00:00:00

  • [Update on lymphomas].

    abstract::Important progress have been recently achieved in the management of Hodgkin's disease (HD) and non-Hodgkin's lymphoma (NHL). Prognostic factors are now better defined in HD thanks to new biologic and radiologic information which complete old and relevant clinical factors. These parameters are expected to improve decis...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Eghbali H,Soubeyran P,Soubeyran I,Monnerau A,Cazorla S

    更新日期:2002-01-01 00:00:00

  • [Supportive care for survivors].

    abstract::Advances in early detection and treatment have pushed in a few decades the management of cancers from a management model of the end of life to the management of a chronic disease. This evolution has accelerated the development of supportive care in two directions, firstly towards the best possible support to the end o...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1016/j.bulcan.2018.04.007

    authors: Ninot G,Debourdeau P,Blanc-Legier F,De Crozals F,De Rauglaudre G,Khouri S,Kirscher S,Mineur L,Piollet I,Sant I,Schillinger P,Serin D

    更新日期:2018-09-01 00:00:00

  • [Li-Fraumeni syndrome].

    abstract::The Li-Fraumeni syndrome is an autosomal dominant syndrome representing a genetic predisposition to a wide spectrum of tumours including sarcomas, breast carcinomas, brain tumors and adrenocortical carcinomas. In most of the cases, tumours will develop in children and young adults. Germline mutations of the tumor supp...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Frebourg T

    更新日期:1997-07-01 00:00:00